A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin

Stopped Registrational study did not meet endpoint so entire program (including CO-101-011) was terminated.

Conditions

• Solid Tumor
• Non-small-cell Lung Cancer
• Lung Cancer

Interventions

• DRUG: CO-1.01 and Cisplatin

Sponsor

Clovis Oncology, Inc.